Expertise in
6
conditions

Stefan S. Heinrich

Trier, RP, DE 
Expertise in
6
conditions
Trier, RP, DE 
OverviewLocationsClinical Research

Overview

Stefan Heinrich practices in Trier, Germany. Mr. Heinrich is highly rated in 6 conditions, according to our data. His top areas of expertise are Liver Cancer, Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Hepato-Pancreato-Biliary Surgery, and Hepatectomy.

His clinical research consists of co-authoring 101 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Trier, RP, Germany
Other Locations
Jena, TH, Germany
Hamburg, HH 21073, Germany
Mainz, RP, Germany
Hugstetter Str. 55, Freiburg, BW 79104, Germany
Dresden, SN 01069, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Perioperative Chemotherapy (FLOT Protocol) Compared To Neoadjuvant Chemoradiation (CROSS Protocol) in Patients With Adenocarcinoma of the Esophagus
Perioperative Chemotherapy (FLOT Protocol) Compared To Neoadjuvant Chemoradiation (CROSS Protocol) in Patients With Adenocarcinoma of the Esophagus
Enrollment Status: Active_not_recruiting
Publish Date: May 08, 2024
Intervention Type: Radiation, Drug
Study Drugs: 5-Fluorouracil, Leucovorin, Oxaliplatin, Docetaxel, Carboplatin, Paclitaxel
Study Phase: Phase 3
Adjuvant Gemcitabine Versus NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic Cancer: a Randomized Multicenter Phase III Study (NEOPAC Study)
Adjuvant Gemcitabine Versus NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic Cancer: a Randomized Multicenter Phase III Study (NEOPAC Study)
Enrollment Status: Terminated
Publish Date: July 25, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

101 Total Publications

No legacy effects of severe drought on carbon and water fluxes in a Mediterranean oak forest.
No legacy effects of severe drought on carbon and water fluxes in a Mediterranean oak forest.
Journal: Plant biology (Stuttgart, Germany)
Published: May 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Heinrich's expertise for a condition
ConditionClose
    View All 19 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile